Quintiles Transnational Holdings Inc., the world’s largest provider of product development and integrated healthcare services, has announced a merger with IMS Health Holdings, Inc., a leading global information and technology services company.
A team of Smith Anderson lawyers served as counsel for Quintiles in this merger of equals agreement. Based on the closing of IMS Health and Quintiles common stock prices on May 2, 2016, the equity market capitalization of the joined companies is more than $17.6 billion and the enterprise value is more than $23 billion.
With this merger, Quintiles IMS Holdings, Inc. will offer a broad range of healthcare information, technology and services solutions to drive efficiencies and insights across the entire life sciences product lifecycle, from R&D through commercial execution to real-world patient outcomes.
According to the Quintiles and IMS Health joint press release, this merger will create one of the world’s largest portfolios of healthcare information, deep therapeutic, domain, regulatory and commercial analytic expertise, as well as proprietary technology applications supported by more than 50,000 employees operating in 100+ countries.
To read the press release in its entirety, please click here.